Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 31232

 

Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 
     
This article has been cited by
1Human papillomavirus DNA, HPV L1 capsid protein and p16INK4a protein as markers to predict cervical lesion progression
Huiyan Hu,Jingjing Zhao,Wen Yu,Junwei Zhao,Zhewei Wang,Lin Jin,Yunyun Yu,Lingfei Han,Lu Wang,Huiting Zhu,Fang Li
Archives of Gynecology and Obstetrics.2019;299(1)141
[DOI]
2Human Papillomavirus Genotyping and p16INK4aExpression in Cervical Lesions: A Combined Test to Avoid Cervical Cancer Progression
Yassine Zouheir,Taoufiq Fechtali,Nadia Elgnaoui
Journal of Cancer Prevention.2016;21(2)121
[DOI]
3Correlation of human papillomavirus 16 and 18 with cervical cancer and their diagnosis methods in Iranian women: A systematic review and meta-analysis
Mona Fani,Pegah Mahmoodi,Maryam Emadzadeh,Amir Avan,Ehsan Karimi,Gordon A. Ferns,Majid Rezayi,Iraj S Amiri
Current Problems in Cancer.2020;44(1)100493
[DOI]
4Cloning and Expression of L1 Protein Human Papillomavirus Type 31 Isolated from Iranian Patients inEscherichia coli
Sameh Hajmohammadi,Hossein Rassi
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.2016;35(4)181
[DOI]
5Systematic review and meta-analysis of human papillomavirus prevalence and types among women with normal cervical cytology in the Eastern Mediterranean Region
Mohammad Farahmand,Zabihollah Shoja,Arash Arashkia,Zahra Salavatiha,Somayeh Jalilvand
Future Virology.2019;14(11)761
[DOI]
6A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix
Philip E. Castle,Amanda Pierz,Mark H. Stoler
Gynecologic Oncology.2018;148(2)422
[DOI]
  Feedback 
  Subscribe 




Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal